Takeaway

• The American Society of Clinical Oncology has issued an update to its 2016 guidelines on which biomarkers to use for early-stage breast cancer.
• 31 recommendations govern the use of genomic biomarkers (e.g., Oncotype DX) or protein (Ki67) biomarkers to shape decisions on endocrine and chemotherapy depending on tumor subtype, menopausal...